Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.39M Sell
9,351
-241
-3% -$82.5K 0.25% 69
2026
Q1
$3.38M Buy
9,592
+85
+0.9% +$30.3K 0.28% 64
2025
Q4
$3.11M Buy
9,507
+441
+5% +$140K 0.25% 68
2025
Q3
$2.56M Hold
9,066
0.23% 65
2025
Q2
$2.53M Sell
9,066
-15
-0.2% -$4.25K 0.25% 62
2025
Q1
$2.83M Sell
9,081
-49
-0.5% -$14.5K 0.3% 61
2024
Q4
$2.38M Hold
9,130
0.25% 58
2024
Q3
$2.94M Sell
9,130
-231
-2% -$75.6K 0.32% 56
2024
Q2
$2.92M Sell
9,361
-60
-0.6% -$17.6K 0.34% 56
2024
Q1
$2.68M Sell
9,421
-500
-5% -$146K 0.32% 56
2023
Q4
$2.86M Buy
9,921
+71
+0.7% +$19.3K 0.37% 53
2023
Q3
$2.65M Sell
9,850
-19
-0.2% -$4.74K 0.4% 51
2023
Q2
$2.19M Buy
9,869
+41
+0.4% +$9.51K 0.32% 52
2023
Q1
$2.38M Buy
9,828
+86
+0.9% +$21.1K 0.38% 52
2022
Q4
$2.56M Sell
9,742
-21
-0.2% -$5.63K 0.47% 50
2022
Q3
$2.2M Sell
9,763
-10
-0.1% -$2.42K 0.43% 51
2022
Q2
$2.38M Buy
9,773
+58
+0.6% +$14.2K 0.43% 53
2022
Q1
$2.35M Sell
9,715
-25,490
-72% -$5.86M 0.36% 58
2021
Q4
$7.92M Sell
35,205
-3,931
-10% -$830K 1.16% 36
2021
Q3
$8.32M Buy
39,136
+425
+1% +$97.8K 1.33% 32
2021
Q2
$9.44M Buy
38,711
+110
+0.3% +$27.1K 1.51% 28
2021
Q1
$9.6M Buy
38,601
+449
+1% +$107K 1.68% 18
2020
Q4
$9.87M Buy
38,152
+352
+0.9% +$81.2K 1.59% 19
2020
Q3
$9.61M Buy
37,800
+298
+0.8% +$73.8K 1.8% 17
2020
Q2
$8.85M Buy
37,502
+8,963
+31% +$2.04M 1.81% 19
2020
Q1
$5.79M Buy
28,539
+395
+1% +$86.3K 1.43% 26
2019
Q4
$6.79M Buy
28,144
+58
+0.2% +$12.8K 1.35% 26
2019
Q3
$6.02M Buy
28,086
+728
+3% +$140K 1.26% 29
2019
Q2
$5.04M Buy
27,358
+210
+0.8% +$37.6K 1.13% 36
2019
Q1
$4.87M Buy
27,148
+871
+3% +$166K 1.1% 37
2018
Q4
$4.89M Buy
26,277
+906
+4% +$177K 1.25% 32
2018
Q3
$4.97M Buy
25,371
+679
+3% +$134K 1.2% 36
2018
Q2
$4.56M Buy
24,692
+677
+3% +$120K 1.22% 38
2018
Q1
$4.09M Buy
24,015
+462
+2% +$84.8K 1.17% 35
2017
Q4
$4.1M Buy
23,553
+995
+4% +$176K 1.19% 38
2017
Q3
$3.88M Hold
22,558
1.3% 36
2017
Q2
$3.88M Buy
22,558
+4,350
+24% +$708K 1.27% 37
2017
Q1
$2.99M Buy
18,208
+2,325
+15% +$386K 1.09% 44
2016
Q4
$2.32M Sell
15,883
-149
-0.9% -$22.4K 0.87% 50
2016
Q3
$2.67M Buy
16,032
+147
+0.9% +$24.9K 1.07% 43
2016
Q2
$2.42M Buy
15,885
+363
+2% +$56.4K 0.98% 45
2016
Q1
$2.33M Buy
15,522
+1,066
+7% +$158K 1% 42
2015
Q4
$2.35M Sell
14,456
-170
-1% -$26.7K 1.02% 44
2015
Q3
$2.02M Buy
14,626
+250
+2% +$39.4K 0.92% 49
2015
Q2
$2.21M Hold
14,376
0.96% 43
2015
Q1
$2.3M Sell
14,376
-349
-2% -$55K 1.03% 43
2014
Q4
$2.35M Sell
14,725
-200
-1% -$31.2K 1.05% 44
2014
Q3
$2.1M Sell
14,925
-25
-0.2% -$3.26K 0.97% 46
2014
Q2
$1.77M Buy
14,950
+10,700
+252% +$1.24M 0.82% 53
2014
Q1
$524K Buy
4,250
+150
+4% +$18.2K 0.26% 74
2013
Q4
$468K Sell
4,100
-400
-9% -$45.5K 0.26% 73
2013
Q3
$504K Buy
4,500
+100
+2% +$10.8K 0.35% 69
2013
Q2
$434K Buy
+4,400
New +$457K 0.32% 70

Other funds holding AMGN

Whitney & Co's AMGN Position: Q2 2026 in Review

Whitney & Co reduced its Amgen (AMGN) stake by 2.5% in Q2 2026, selling an estimated $82.5K and leaving 9,351 shares worth $3.39M. The position accounts for 0.25% of the portfolio, ranked #69.

Whitney & Co first reported a position in AMGN in Q2 2013 and has held it in 53 quarters since. The position peaked at $9.87M in Q4 2020. 1,515 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Whitney & Co held 9,351 shares of Amgen worth $3.39M as of Q2 2026.
  • Whitney & Co sold 241 Amgen shares in Q2 2026, an estimated $82.5K.
  • Amgen made up 0.25% of Whitney & Co's portfolio in Q2 2026, its #69 holding.
  • Whitney & Co first reported a position in Amgen in Q2 2013 and has held it in 53 quarters since.
  • Whitney & Co's Amgen position peaked at $9.87M in Q4 2020.
  • 1,515 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Whitney & Co's 13F filing for Q2 2026, filed 28 Jul 2026.